SubHero Banner

Cimduo (lamivudine/tenofovir disoproxil fumarate) – New drug approval

March 2, 2018 - Mylan announced the FDA approval of Cimduo (lamivudine/tenofovir disoproxil fumarate), to be used in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 35 kg.

Download PDF